| Code | Description | Claims | Beneficiaries | Total Paid |
| J9271 |
Injection, pembrolizumab, 1 mg |
749 |
630 |
$7.13M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,483 |
16,072 |
$4.77M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,200 |
14,131 |
$4.06M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,345 |
5,817 |
$3.08M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,407 |
1,399 |
$1.49M |
| 80053 |
Comprehensive metabolic panel |
35,061 |
22,264 |
$1.29M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,581 |
4,186 |
$1.11M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,022 |
4,976 |
$715K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,214 |
1,599 |
$688K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,160 |
2,075 |
$670K |
| 86850 |
|
7,495 |
5,313 |
$596K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,018 |
2,753 |
$573K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,885 |
3,830 |
$568K |
| 77336 |
|
2,330 |
1,205 |
$522K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,102 |
2,079 |
$432K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
1,800 |
1,434 |
$404K |
| J0185 |
Injection, aprepitant, 1 mg |
1,149 |
833 |
$362K |
| 77412 |
|
1,546 |
201 |
$347K |
| 36415 |
Collection of venous blood by venipuncture |
33,428 |
18,733 |
$330K |
| 31575 |
|
767 |
755 |
$320K |
| 96409 |
|
1,025 |
631 |
$303K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,861 |
3,354 |
$269K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,450 |
1,132 |
$240K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,290 |
864 |
$239K |
| Q3014 |
Telehealth originating site facility fee |
877 |
840 |
$222K |
| 77386 |
|
640 |
56 |
$216K |
| 96411 |
|
1,466 |
1,039 |
$202K |
| 82565 |
|
1,465 |
1,431 |
$200K |
| J9306 |
Injection, pertuzumab, 1 mg |
36 |
25 |
$197K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,478 |
1,513 |
$187K |
| 36430 |
|
1,844 |
1,274 |
$182K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,766 |
2,944 |
$177K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,822 |
20,794 |
$164K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,268 |
2,268 |
$160K |
| 71250 |
|
1,381 |
1,370 |
$145K |
| J3490 |
Unclassified drugs |
2,182 |
1,333 |
$144K |
| 88185 |
|
1,340 |
1,146 |
$140K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
730 |
722 |
$136K |
| 77049 |
|
426 |
425 |
$123K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
950 |
924 |
$121K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,549 |
4,250 |
$121K |
| 96402 |
|
473 |
443 |
$118K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
355 |
291 |
$110K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,641 |
1,506 |
$109K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
28 |
26 |
$100K |
| 99215 |
Prolong outpt/office vis |
388 |
380 |
$98K |
| 96417 |
|
2,325 |
1,572 |
$97K |
| 88341 |
|
1,306 |
1,232 |
$96K |
| 96415 |
|
2,115 |
1,235 |
$92K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
49 |
49 |
$88K |
| J9305 |
Injection, pemetrexed, not otherwise specified, 10 mg |
12 |
12 |
$87K |
| 77066 |
Tomosynthesis, mammo |
957 |
953 |
$84K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,268 |
2,268 |
$82K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,897 |
2,689 |
$81K |
| 77334 |
|
590 |
532 |
$72K |
| J9045 |
Injection, carboplatin, 50 mg |
1,117 |
768 |
$67K |
| 77300 |
|
453 |
439 |
$67K |
| 86923 |
|
1,496 |
1,155 |
$65K |
| 96367 |
|
386 |
251 |
$65K |
| 11102 |
|
149 |
146 |
$64K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
666 |
345 |
$62K |
| 70491 |
|
463 |
458 |
$60K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
556 |
515 |
$57K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
268 |
256 |
$50K |
| 83521 |
|
387 |
366 |
$50K |
| 76642 |
|
1,111 |
1,108 |
$47K |
| 0002A |
|
272 |
272 |
$46K |
| 87631 |
|
738 |
688 |
$44K |
| 76536 |
|
847 |
844 |
$42K |
| 36561 |
|
26 |
25 |
$41K |
| 83615 |
|
13,189 |
9,136 |
$37K |
| 77065 |
Tomosynthesis, mammo |
540 |
525 |
$37K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
499 |
369 |
$33K |
| 77280 |
|
99 |
77 |
$31K |
| J9267 |
Injection, paclitaxel, 1 mg |
475 |
261 |
$29K |
| 76942 |
|
392 |
388 |
$27K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,403 |
1,881 |
$27K |
| 88342 |
|
1,779 |
1,712 |
$27K |
| 85027 |
|
5,674 |
4,234 |
$26K |
| J9070 |
Cyclophosphamide, 100 mg |
47 |
25 |
$26K |
| 82378 |
|
2,119 |
1,846 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,228 |
2,957 |
$25K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
13 |
$24K |
| 82728 |
|
3,237 |
2,979 |
$24K |
| 84436 |
|
1,340 |
1,286 |
$24K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$24K |
| 86900 |
|
7,704 |
5,388 |
$22K |
| 82784 |
|
1,478 |
1,316 |
$22K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,889 |
2,396 |
$21K |
| 74183 |
|
52 |
52 |
$19K |
| 88184 |
|
1,324 |
1,141 |
$19K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,079 |
1,363 |
$19K |
| 86901 |
|
7,707 |
5,388 |
$19K |
| 85007 |
|
5,820 |
3,598 |
$18K |
| 83735 |
|
5,945 |
3,272 |
$18K |
| 38222 |
|
53 |
52 |
$17K |
| 36593 |
|
59 |
53 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,676 |
1,663 |
$17K |
| 74178 |
|
94 |
94 |
$16K |
| 86304 |
|
581 |
539 |
$15K |
| 88360 |
|
473 |
466 |
$15K |
| 78306 |
|
119 |
118 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,171 |
1,163 |
$14K |
| 84550 |
|
5,651 |
3,270 |
$14K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
2,109 |
1,190 |
$14K |
| 81025 |
|
1,403 |
1,331 |
$13K |
| 84100 |
|
4,930 |
3,078 |
$12K |
| 87486 |
|
480 |
443 |
$12K |
| 88307 |
|
455 |
445 |
$11K |
| 82948 |
|
264 |
216 |
$11K |
| 0001A |
|
91 |
91 |
$11K |
| 84432 |
|
108 |
103 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
636 |
616 |
$11K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
2,657 |
1,413 |
$11K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
56 |
52 |
$11K |
| 90686 |
|
569 |
567 |
$10K |
| 84153 |
|
410 |
390 |
$10K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
306 |
305 |
$10K |
| 83020 |
|
1,598 |
1,438 |
$9K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
86 |
49 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
569 |
514 |
$9K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,162 |
969 |
$9K |
| 87088 |
|
909 |
859 |
$8K |
| 94010 |
|
127 |
125 |
$8K |
| 86300 |
|
872 |
692 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
468 |
409 |
$8K |
| 86902 |
|
239 |
210 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
2,476 |
2,254 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,881 |
2,768 |
$7K |
| 87496 |
|
513 |
272 |
$7K |
| J9370 |
Vincristine sulfate, 1 mg |
578 |
411 |
$7K |
| 86334 |
|
530 |
498 |
$6K |
| 85610 |
|
1,534 |
1,322 |
$6K |
| 87497 |
|
95 |
38 |
$6K |
| 85045 |
|
3,544 |
3,139 |
$5K |
| 84484 |
|
802 |
631 |
$5K |
| 88112 |
|
197 |
193 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
80 |
39 |
$5K |
| 77295 |
|
24 |
24 |
$5K |
| 87581 |
|
481 |
444 |
$5K |
| 94729 |
|
215 |
210 |
$5K |
| 83880 |
|
231 |
217 |
$4K |
| 81003 |
|
2,216 |
2,082 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,373 |
1,482 |
$4K |
| 81206 |
|
40 |
38 |
$4K |
| 87040 |
|
504 |
446 |
$4K |
| 76641 |
|
66 |
66 |
$4K |
| 84480 |
|
1,406 |
1,350 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,126 |
990 |
$4K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,318 |
1,235 |
$4K |
| C1788 |
Port, indwelling (implantable) |
24 |
24 |
$4K |
| 94726 |
|
170 |
166 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
47 |
46 |
$3K |
| J3489 |
Injection, zoledronic acid, 1 mg |
41 |
39 |
$3K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
42 |
25 |
$3K |
| J2545 |
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
19 |
17 |
$3K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
55 |
37 |
$3K |
| 86704 |
|
394 |
379 |
$3K |
| 97162 |
|
42 |
41 |
$2K |
| 84165 |
|
584 |
548 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,693 |
2,582 |
$2K |
| 83605 |
|
473 |
427 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,232 |
3,078 |
$2K |
| 87070 |
|
333 |
316 |
$2K |
| 77080 |
|
57 |
57 |
$2K |
| 71271 |
|
52 |
52 |
$2K |
| 84439 |
|
128 |
123 |
$2K |
| 85046 |
|
817 |
731 |
$2K |
| 82105 |
|
185 |
170 |
$2K |
| 83883 |
|
102 |
95 |
$2K |
| 94060 |
|
24 |
24 |
$2K |
| 86803 |
|
435 |
422 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
118 |
96 |
$2K |
| 87340 |
|
403 |
391 |
$2K |
| 82607 |
|
265 |
260 |
$2K |
| 81450 |
|
41 |
38 |
$1K |
| 85097 |
|
63 |
62 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
100 |
94 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,609 |
3,422 |
$1K |
| D0120 |
Periodic oral evaluation - established patient |
24 |
13 |
$1K |
| 85730 |
|
367 |
313 |
$1K |
| J1453 |
Injection, fosaprepitant, 1 mg |
14 |
12 |
$1K |
| 86140 |
|
416 |
369 |
$1K |
| 77001 |
|
40 |
38 |
$1K |
| 86706 |
|
163 |
160 |
$1K |
| 83921 |
|
30 |
29 |
$1K |
| 70487 |
|
13 |
13 |
$957.26 |
| 83540 |
|
488 |
479 |
$949.36 |
| 83550 |
|
472 |
463 |
$911.24 |
| 76937 |
|
40 |
38 |
$867.26 |
| 71045 |
Radiologic examination, chest; single view |
99 |
90 |
$852.04 |
| 87077 |
|
47 |
43 |
$751.14 |
| 88237 |
|
12 |
12 |
$728.88 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
77 |
48 |
$686.68 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
307 |
180 |
$685.30 |
| 82550 |
|
100 |
82 |
$684.90 |
| 85660 |
|
195 |
180 |
$675.15 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
394 |
351 |
$664.24 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,732 |
1,008 |
$656.04 |
| 86800 |
|
135 |
130 |
$649.78 |
| J1644 |
Injection, heparin sodium, per 1000 units |
637 |
453 |
$622.52 |
| 88142 |
|
39 |
39 |
$614.38 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
57 |
57 |
$496.64 |
| 81015 |
|
1,002 |
955 |
$409.01 |
| 87205 |
|
201 |
189 |
$321.11 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
24 |
24 |
$313.40 |
| J9250 |
Methotrexate sodium, 5 mg |
169 |
84 |
$309.56 |
| 88162 |
|
53 |
53 |
$306.78 |
| 88108 |
|
29 |
27 |
$260.54 |
| 86301 |
|
25 |
25 |
$259.00 |
| 87799 |
|
14 |
12 |
$237.95 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$236.54 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
18 |
13 |
$213.52 |
| 94642 |
|
17 |
15 |
$208.73 |
| 88311 |
|
38 |
38 |
$175.97 |
| 83090 |
|
17 |
17 |
$172.34 |
| 82668 |
|
14 |
14 |
$149.89 |
| 88313 |
|
12 |
12 |
$139.28 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
40 |
36 |
$139.07 |
| 80061 |
Lipid panel |
29 |
27 |
$134.04 |
| 82248 |
|
58 |
27 |
$127.67 |
| 85651 |
|
157 |
141 |
$126.41 |
| 84157 |
|
81 |
66 |
$125.92 |
| 82945 |
|
83 |
68 |
$125.30 |
| 82570 |
|
67 |
64 |
$112.17 |
| 89050 |
|
82 |
68 |
$106.83 |
| 83021 |
|
14 |
13 |
$104.24 |
| 82747 |
|
12 |
12 |
$95.16 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$90.25 |
| 86703 |
|
17 |
17 |
$85.51 |
| 87186 |
|
15 |
13 |
$77.73 |
| 83690 |
|
31 |
24 |
$70.64 |
| 89051 |
|
31 |
28 |
$64.88 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
116 |
77 |
$61.82 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
47 |
45 |
$60.97 |
| 85652 |
|
58 |
56 |
$54.21 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
69 |
52 |
$49.02 |
| 82150 |
|
31 |
24 |
$45.19 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
1,215 |
799 |
$42.85 |
| S0028 |
Injection, famotidine, 20 mg |
46 |
32 |
$42.56 |
| 84156 |
|
14 |
12 |
$18.35 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
41 |
40 |
$2.52 |